Drug Development Technology is using cookies

We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.

ContinueLearn More X
X

Modus Therapeutics initiates Phase I trial of sevuparin injections

SCD is a genetic blood disorder characterised by severely painful VOCs that lead to organ damage. Credit: National Center for Advancing Translational Sciences (NCATS), National Institutes of Health.



  • Modus Therapeutics initiates Phase I trial of sevuparin injections

Go Top